Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy

Authors

Keywords

Journal

Volume 13, Issue 4, Pages 367-369

Publisher

Springer Nature

Online

2009-11-13

DOI

10.1007/s12603-009-0046-5

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started